We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Paper Replaces Nitrocellulose in New Rapid Test for Morphine

By LabMedica International staff writers
Posted on 28 Apr 2015
Print article
Image: Paper replaced nitrocellulose as support material in a new rapid assay for morphine (Photo courtesy of VTT).
Image: Paper replaced nitrocellulose as support material in a new rapid assay for morphine (Photo courtesy of VTT).
A recent paper described the use of paper as the support material for a rapid diagnostic test for detection of morphine in saliva.

Investigators at the biomedical company VTT (Espoo, Finland) used morphine as a model analyte to examine the possibility of using cellulose, physically modified by papermaking and converting techniques, as a capillary matrix in a lateral flow type of diagnostic assay. In this case, paper replaced the generally used nitrocellulose support material.

The investigators developed a "sandwich" lateral flow assay that incorporated antibody Fab fragments as sensing molecules and employed gold nanoparticle visual detection. Inkjet printing was used to pattern sensing biomolecules as detection zones on the paper.

Results were compared with those achieved by using nitrocellulose as the test support material. Possible interference from the sample matrix on assay quality was investigated with spiked oral fluid samples.

Under optimized conditions, a visually assessed limit of detection for the assay was one nanogram per milliliter, indicating that the paper-based test devices developed in this work could perform screening for drugs of abuse and could fulfill the requirement for a sensitive assay in diagnostically relevant ranges.

"In 2010, we proved that the VTT method works in a hemoglobin assay. Through our continued development efforts, we wanted to confirm that the method also works in mass-production of more demanding tests. Morphine as a small-sized molecule places major requirements on the analytical performance of the test. In the future, the new method will also present an opportunity to simultaneously analyze other drugs of abuse and residues of pharmaceuticals and their metabolites from one and the same sample,” said Dr. Tomi Erho, principal scientist at VTT.

Details of the paper-based morphine test were published in the September 2014 issue of the journal Analytical and Bioanalytical Chemistry.

Related Links:

VTT


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.